Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Several immune escape patterns in non-Hodgkin's lymphomas
Camille Laurent1, Konstantina Charmpi2, Pauline Gravelle1
1Institut Universitaire du Cancer-Oncopole de Toulouse ; Toulouse, France ; Centre de Recherches en Cancérologie de Toulouse; INSERM UMR1037 ; Toulouse, France ; Université Toulouse III Paul-Sabatier ; Toulouse, France ; ERL 5294 CNRS ; Toulouse, France ; Programme Hospitalo-Universitaire en Cancérologie CAPTOR ; Toulouse, France ; Institut Carnot Lymphome CALYM ; Toulouse, France ; Laboratoire d'Excellence 'TOUCAN' ; Toulouse, France.
Follicular lymphomas (FL) and diffuse large B cell lymphomas (DLBCL) use immune escape strategies involving PD-1, PD-L1, PD-L2, and LAG3. DLBCL exhibits distinct immune evasion pathways compared to FL.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Follicular lymphomas (FL) and diffuse large B cell lymphomas (DLBCL) require immune escape mechanisms for development.
- The specific immune evasion pathways utilized by these lymphomas are not well understood.
Purpose of the Study:
- To investigate and characterize the immune escape strategies employed by FL and DLBCL.
- To compare the expression of key immune checkpoint genes and proteins in FL, DLBCL, and normal B cells.
Main Methods:
- Transcriptome data mining of FL and DLBCL biopsies.
- Definition and analysis of an Immune Escape Gene Set (IEGS).
- Immunohistochemistry (IHC) on tissue microarrays of patient biopsies to confirm protein expression.
Main Results:
- The IEGS, including PD-1, PD-L1, PD-L2, and LAG3, was significantly upregulated in lymphoma samples compared to normal B cells.
- FL samples showed more immune infiltrates and higher rates of PD-1+ lymphocytes.
- DLBCL tumor cells exhibited higher proportions of PD-1+, PD-L1+, PD-L2+, and LAG3+ cells, indicating distinct immune escape strategies.
Conclusions:
- FL and DLBCL utilize distinct immune escape pathways.
- The findings highlight the role of PD-1, PD-L1, PD-L2, and LAG3 in lymphoma immune evasion.
- Activated B cell subtype DLBCL showed higher PD-L1 and PD-L2 expression than the germinal center subtype.
Related Concept Videos
Treatment Resistant Cancers
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...

